Adverse Outcomes in Non-ST-Elevation Acute Coronary Syndrome: A Cluster Analysis Study

Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS) represents a significant subset of acute coronary syndromes, characterized by substantial morbidity and mortality risks. Despite advancements in diagnosis and treatment, predicting adverse outcomes remains challenging due to the heterogeneity in patient presentations and disease progression. This study uses cluster analysis to identify patient subgroups associated with specific risks, providing insights into tailored management strategies.

https://cvia-journal.org/instructions-to-authors/

---

Introduction

1. Understanding NSTE-ACS
   
   
   
   • NSTE-ACS includes unstable angina (UA) and non-ST-elevation myocardial infarction (NSTEMI).
   
   
   • The lack of distinct ST-segment elevation on ECG makes risk stratification crucial for effective treatment.
   
   
   
   


2. Significance of Cluster Analysis
   
   
   
   • Cluster analysis is a statistical method that groups patients based on shared clinical and biological features.
   
   
   • This approach identifies patterns in patient data, enabling targeted interventions for high-risk subgroups.
   
   
   
   

---

Methods

1. Study Population
   
   
   
   • Data were collected from patients diagnosed with NSTE-ACS in tertiary care centers.
   
   
   • Clinical parameters, laboratory values, imaging findings, and treatment histories were analyzed.
   
   
   
   


2. Cluster Analysis Approach
   
   
   
   • Variables included troponin levels, GRACE scores, comorbidities (e.g., diabetes, hypertension), and angiographic findings.
   
   
   • Clusters were formed using unsupervised machine learning algorithms like k-means or hierarchical clustering.
   
   
   
   

---

Results

1. Identification of Patient Clusters
   
   
   
   • Cluster 1: Younger patients with minimal comorbidities and lower GRACE scores. Outcome: Favorable prognosis.
   
   
   • Cluster 2: Patients with multiple comorbidities (e.g., diabetes, chronic kidney disease) and high inflammatory markers. Outcome: Increased risk of in-hospital mortality.
   
   
   • Cluster 3: Older patients with prior cardiovascular events and significant coronary artery disease. Outcome: Higher rates of recurrent myocardial infarction and heart failure.
   
   
   
   


2. Adverse Outcomes by Cluster
   
   
   
   • Mortality, recurrent ischemic events, and complications like cardiogenic shock were significantly higher in Clusters 2 and 3.
   
   
   • Clusters revealed distinct therapeutic gaps, particularly underutilization of invasive management strategies in high-risk groups.
   
   
   
   

---

Discussion

1. Insights into Risk Stratification
   
   
   
   • Cluster analysis confirms the heterogeneity in NSTE-ACS patient outcomes, emphasizing the need for individualized treatment approaches.
   
   
   • High-risk clusters may benefit from aggressive therapies such as early revascularization and intensive medical management.
   
   
   
   


2. Clinical Implications
   
   
   
   • Predicting adverse outcomes allows clinicians to allocate resources effectively.
   
   
   • Incorporating cluster analysis into decision-making tools may improve guideline adherence and reduce disparities in care.
   
   
   
   

---

Conclusion

This cluster analysis highlights the diverse profiles of NSTE-ACS patients and their associated risks for adverse outcomes. Identifying high-risk groups enables clinicians to tailor therapeutic strategies, ultimately improving patient prognosis and reducing healthcare burdens. Future research should focus on validating these findings in larger, multi-center cohorts and integrating cluster-based approaches into clinical practice.